scholarly journals CHARACTERIZATION OF GASTROESOPHAGEAL REFLUX ACCORDING TO PH-IMPEDANSOMETRY

2020 ◽  
pp. 40-43
Author(s):  
V. V. Komarchuk ◽  
E. V. Komarchuk ◽  
А. S. Trushin ◽  
A. V. Gorbulich ◽  
A. A. Sheptukha ◽  
...  

Summary. Aim. To study the characteristics of gastroesophageal reflux using pH-impedance monitoring. Materials and methods. pH-impedance monitoring was carried out in 38 patients with GERD symptoms without endoscopic signs and 22 patients with endoscopic signs of reflux esophagitis and reflux gastritis. Results. All studied parameters confirmed the physiological nature of GER in 38 patients of group I and 9 patients of group II; the presence of pathological GER and impaired gastroesophageal antireflux barrier function in 13 patients of group II. Conclusions. The conducted pH-impedance monitoring made it possible to determine not only acidic GER and superrefluxes, but also weakly acidic and weakly alkaline ones, most accurately obtain quantitative and qualitative characteristics of GER, as well as establish a violation of the chemical and volumetric clearance of the esophagus. The data obtained can be used when choosing the method of antireflux surgery in patients with GERD.

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1821.1-1821
Author(s):  
M. Sukhareva ◽  
O. Egorova ◽  
B. Belov

Background:In medical practice lobular panniculitis-lipodermatosclerosis (LDS) is becoming more and more common. It is manifested by degenerative-dystrophic changes in subcutaneous fat (SCF) and occurs more often in middle-aged women affected by chronic venous insufficiency.Objectives:to evaluate the effectiveness of mesotherapy (MT) and shockwave ultrasound therapy (UST) for LDSMethods:among 539 patients referred to the V.A. Nasonova Research Institute of Rheumatology with the referral diagnoses of erythema nodosum or panniculitis 8.5% (46) of patients (44 women, 2 men) aged 18 to 82 with overweight (32) LDS with the disease duration of 11,8±6.4 months was verified. Patients were randomized into two groups of 23 patients each: group I received daily MT (10 sessions) therapy with drugs that have antioxidant, anti-inflammatory, lymphatic drainage and lipolytic effects, and 3 MHz UST of the node area twice a week (5 sessions). In group II MT was performed daily with 9% Natrii chloridum solution at a dose comparable to group I. The control methods included general clinical examination (characterization of induration on the lower legs with an assessment of the effect of pain pressing according to visual analogue scale (VAS pain), general blood and urine tests and ultrasound with elastography (USE) of the compaction. The main stages of control: initial (T0), after 14 days (T1), 1 month (T2) and 3 months (T3).Results:before treatment 38 patients with LDS demonstrated asymmetric (83%) inflammation of SCF of the lower legs (100%) on its medial surface (91%). LDS regressed faster with normal body mass index (p = 0,04). In all patients of group I, after a course of physiotherapy a positive trend was registered, that is a decrease in VAS pain intensity (T0 50±18 mm; T1 35±11 mm), decrease in diameter (T0 6±2.2 cm; T1 4.5±1, 7 mm) and color intensity of the node (p<0.002), SCF thickening which results in “lumping” with macrovascularization according to USE, and decrease in ESR and CRP. In 44% of cases the treatment effect increased to T2 (p <0.05). After 3 months of observation, 15 patients required a second course of physiotherapy. In group II a positive clinical effect was registered for T2 in 14 patients (60.8%) and for T3 in 19 patients (83%) (p<0.05). Over the entire observation period LDS recurrence was registered in 19 patients (41%), the median of recurrence was 3 [1; 6] months, mainly in patients of group I. Recurrence was associated with node fusion into conglomerates (OR 4.33, 95% CI 1.05-17.8; p = 0.037). MT and UST were tolerated well, no side effects were detected.Conclusion:the use of MT with 9% Natrii chloridum solution allowed us to achieve positive dynamics in patients with LDS, which significantly reduced the cost of treatment. Further studies are needed to evaluate the significance of these techniques.Disclosure of Interests:None declared


2020 ◽  
Vol 3 (1) ◽  
pp. 11-16
Author(s):  
Iryna Romash

Introduction. It has been scientifically confirmed that the risk of developing gastroesophageal reflux disease (GERD) increases especially with generalized or regional disruption of connective tissue structure, which is widespread among the population. Patients with such comorbid pathology may have a wide range of symptoms that may go beyond the general symptoms of heartburn and regurgitation. The symptoms and complications of GERD affect general health, daily and social functioning, physical and emotional activity. It also affects the quality of life (QoL) associated with health through frequent breaks during sleep, work and social activities. Purpose. study the dynamics of the level of quality of life and social functioning in patients with gastroesophageal reflux disease in combination with the syndrome of undifferentiated connective tissue dysplasia. Methodology. A total of 120 patients were included in the study: 65 men and 55 women: in 75 of them (Group II) GERD occurred on the background of UCTD, in 45 (Group I) as an independent disease. The control group consisted of 12 healthy individuals. The study was comprehensive. The Medical Outcomes Study 36-Item Short-Form Health Status (SF-36),the Gastrointestinal Symptom Rating Scale (GSRS) and the scale of "Personal and social performance" (PSP) -  were used to study patients in detail. Results and Discussion. Analyzing the results obtained on the basis of the GSRS questionnaire (Table 1), in patients with GERD on the background of UCTD, compared with patients of group I and the control group, there is a significant increase in three and four from the five scales. QoL in patients of Group II on the scale "Abdominal pain" were 14.3 ± 0.4 points, in Group I - 5.6 ± 1.3 points, in the Control Group - 2.4 ± 0.8 points, on the scale "Reflux syndrome": 13.7 ± 0.9, 10.5 ± 1.3 and 3.1 ± 0.9, respectively. "Dyspeptic syndrome" - 15.3 ± 0.4 points in Group II, 12.2 ± 0.6- in Group I and 6.1 ± 0.3- in the control group. "Constipation syndrome" 9.5 ± 0.8, 5.6 ± 1.03 and 5.7 ± 0.4, respectively (p <0,05). Conclusions: In this research we investigated the effect of comorbid pathology on QoL in patients with GERD, which developed against the background of UCTD. The results confirm that patients with such combined pathology have a lower level of quality of life and social functioning, and the tactics of treatment of such patients should take into account these changes


2002 ◽  
Vol 39 (2) ◽  
pp. 123-125 ◽  
Author(s):  
Luciana Dias MORETZSOHN ◽  
Eliza Maria de BRITO ◽  
Margareth Souza Ferreira REIS ◽  
Luiz Gonzaga Vaz COELHO ◽  
Luiz de Paula CASTRO

Background - Gastroesophageal reflux disease is a very common affection, and esophageal involvement is particularly frequent. The means to effectively control symptoms and improve esophageal inflammation in these patients is to reduce esophageal acid exposure. For this purpose, we use gastric proton pump inhibitor, that can suppress gastric acid secretion. Aim - To compare the effectiveness of two different pantoprazole dosage regimens (20 and 40 mg/day), in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis. Material and Methods - Fifty-seven patients with endoscopically confirmed mild erosive esophagitis characterized as non-confluent erosions in the distal esophagus, were randomly to be treated either with pantoprazole 20 mg/day (group I, 28 patients) or 40 mg/day (group II, 29 patients) over a period of 4 weeks. After treatment completion, the patients were assessed for clinical and endoscopic outcome, i.e., absence of erosions in distal esophagus and improvement of gastroesophageal reflux symptoms. Results - At the end of the treatment, 73.1% of the patients in group I and 85.7% of the patients in group II had endoscopic improvement. We also observed, that 88.5% of the patients in group I and 92.9% of the patients in group II had complete elimination of heartburn and regurgitation. Conclusion - Pantoprazole dosage regimens of 20 mg/day and 40 mg/day provide equivalent effectiveness in controlling symptoms and healing esophageal lesions of mild esophagitis.


2016 ◽  
Vol 17 (2) ◽  
pp. 99-104 ◽  
Author(s):  
Ayman Al-Dharrab ◽  
Lana Shinawi

ABSTRACT Background Thermoplastic resin polymers are widely used in medicine due to their biostability and hypoallergenic properties, making them a possible alternative to poly-methylmethacrylate (PMMA). The current research examined the microstructure of a rapid injection molding system thermoplastic resin for construction of flexible denture compared with that of heatcured PMMA. Materials and methods A total of 40 disk-shaped specimens (25 mm in diameter and 3 mm in thickness) were prepared and divided into two groups of 20 disks each (group I samples were of thermoplastic acrylic resin while group II was heat-cured PMMA resin). Results In group I, thermogravimetric analyzer showed that increasing the temperature up to 169°C resulted in about 1.3% of the material loss, and after that the material remains thermally stable up to 200°C. Group II showed 2.24% weight loss at 171°C, and further weight loss (12.025%) was observed on heating to 230°C. Fourier transform infrared (FTIR) spectrophotometer analysis in the range of 400–4000 cm-1 detected the presence of an amine group (N-H) in group I samples and the presence of methylene group attached to inorganic Si as reinforcement filler (Si-CH3). Conclusion Thermoplastic resin displayed excellent thermal stability and the absence of residual monomer within the polymerized material, suggesting its suitability for the fabrication dentures. How to cite this article Al-Dharrab A, Shinawi L. Thermogravimetric Characterization of the Microstructure Composition of Polyamide Injection Molded Denture Base Material vs Conventional Compression Molded Heat-cured Denture Base Material. J Contemp Dent Pract 2016;17(2):99-104.


Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 3609-3609
Author(s):  
Helen Rooks ◽  
Jean Bergounioux ◽  
Laurence Game ◽  
James P. Close ◽  
Steve Best ◽  
...  

Abstract The thalassemias are inherited disorders classified genetically into α, β, γ, δβ, δ and εγδβ varieties according to the type of globin(s) that are underproduced. At the molecular level, the εγδβ thalassemias fall into two categories; Group I removes all, or a greater part, of the β globin gene cluster which is embedded in an array of olfactory receptor genes on chromosome 11p15. Group II removes extensive upstream regions leaving the β globin gene itself intact despite which, its expression is silenced due to inactivation of the upstream locus control region (β LCR). Recently, two novel deletions causing εγδβ thalassemia have been reported; a 153 kb deletion removing the entire β globin cluster in a Chilean family (Game, L., et al., Br J Haematol2003, 123:154–9) and an upstream deletion of 112 kb in a Dutch family (Dutch III) (Harteveld, C.L., et al., Br J Haematol2003,122: 855–8). We describe here the characterization of another three novel εγδβ thalassemia deletions, in three English families, named English II, III and IV, to differentiate them from the previously reported English (I) deletion (Curtin, P., et al., J Clin Invest1985, 76: 1554–8). Deletion English II removed 98 kb extending 90 kb upstream of the ε gene to 8 kb upstream of the Gγ gene, and included 4 upstream olfactory receptor (HOR) genes. Deletion English III removed 114 kb extending 60 kb upstream of the ε gene to 9 kb downstream of the β globin gene, thus including the entire β globin gene cluster as well as two upstream HOR genes. English IV is the largest deletion (439 kb) reported so far; starting 326 kb upstream of the ε gene to 70 kb downstream of the β gene and included 13 upstream, and 3 downstream, HOR genes plus the intervening β globin gene cluster. Breakpoints of all the 3 deletions occurred within regions of L1 or Alu repeat elements and contained short regions of direct homology between the flanking sequences, a feature that is likely to have contributed to the illegitimate recombinations. Deletions English II and III appear to be de novo while English IV is not. The proband for the English IV deletion had neonatal hemolytic anemia and required blood transfusions while 3 other family members who were heterozygous for the same deletion, had uneventful post-natal periods. The English III proband also required a blood transfusion soon after birth while the English II proband did not. Although in later life, heterozygotes for εγδβ thalassemia are transfusion-independent, and have a blood picture typical of β thalassemia trait but with normal Hb A2 levels, our data suggest that heterozygotes for εγδβ thalassemias have more severe microcytosis and hypochromia than β thalassemia carriers. To date, a total of 15 deletions causing εγδβ thalassemia have been described - five upstream deletions (Group II) associated with intact β globin genes and ten (Group I) that include the entire β globin gene cluster. These deletions are all unique and illustrate the heterogeneity of the εγδβ thalassemias.


1968 ◽  
Vol 128 (4) ◽  
pp. 699-713 ◽  
Author(s):  
Joseph M. Davie ◽  
C. Kirk Osterland

A survey of human pathological macroglobulins revealed that γM can be divided into at least two groups on the basis of carbohydrate composition. Differences between the two groups exist in the total percentage of carbohydrate (10.69 ± 1.49% for group 1, 7.71 ± 0.65% for group II) which is attributable to variation in hexose content. Glycopeptides from macroglobulins of each group were purified from pronase digests and characterized chemically. Macroglobulins from each group contain three types of oligosaccharides. Glycopeptide I for each group consisted of mannose, galactose, and NAG with a ratio of 3:2:1 for group I and a ratio of 2:1:2 for group II. Glycopeptide II consisted of mannose, galactose, and NAG (9:1:2) for group I, and mannose, fucose, galactose, and NAG (2:1:3:2) for group II. Glycopeptide III in both groups consisted of mannose, fucose, galactose, NAG, and sialic acid with a ratio of 6:2.5:2.5:5.5:2 for group I and a ratio of 5:1:1:6:1 for group II. Molecular weight estimations by gel filtration indicates that there are 10 glycopeptides I and II and 20 units of glycopeptide III per molecule of γM.


2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Mohamed Laimoud ◽  
Farouk Faris ◽  
Helmy Elghawaby

Background. Non-ST elevation acute coronary syndromes (NSTE-ACS) may arise from moderately stenosed atherosclerotic lesions that suddenly undergo transformation to vulnerable plaques complicated by rupture and thrombosis. Objective. Assessment and tissue characterization of the coronary atherosclerotic lesions among NSTE-ACS patients compared to those with stable angina. Methodology. Evaluation of IVUS studies of 312 coronary lesions was done by 2 different experienced IVUS readers, 216 lesions in 66 patients with NSTE-ACS (group I) versus 96 lesions in 50 patients with stable angina (group II). Characterization of coronary plaques structure was done using colored-coded iMap technique. Results. The Syntax score was significantly higher in group I compared to group II (18.7 ± 7.8 vs. 8.07 ± 2.5, p=0.001). Body mass index (BMI) was significantly higher in group II while triglycerides levels were higher in group I (P=0.01 & P=0.04, respectively). History of previous MI and PCI was significantly higher in group I (P=0.016 & P=0.001, respectively). The coronary lesions of NSTE-ACS patients had less vessel area (9.86 ± 3.8 vs 11.36 ± 2.9, p=0.001), stenosis percentage (54.7 ± 14.9% vs 68.6 ± 8.7%, p=0.001), and plaque burden (54.4 ± 14.7 vs 67.8 ± 9.8, p=0.001) with negative remodeling index (0.95 ± 20 vs 1.02 ± 0.14, p=0.008) compared to the stable angina group. On the other hand, they had more lipid content (21.8 ± 7.03% vs 7.26 ± 3.47%, p=0.001), necrotic core (18.08 ± 10.19% vs 15.83 ± 4.9%, p=0.02), and calcifications (10.4 ± 5.2% vs 4.19 ± 3.29%, p=0.001) while less fibrosis (51.67 ± 7.07% vs 70.37 ± 11.7%, p=0.001) compared to the stable angina patients. Syntax score and core composition especially calcification and lipid content were significant predictors to NSTE-ACS. Conclusions. The vulnerability rather than the stenotic severity is the most important factor that predisposes to non-ST segment elevation acute coronary syndromes. The vulnerability is related to the lesion characteristics especially lipidic core and calcification while lesion fibrosis favours lesion stability.


1982 ◽  
Vol 203 (1) ◽  
pp. 131-139 ◽  
Author(s):  
S Visser ◽  
R Jenness ◽  
R J Mullin

Three groups of casein components were isolated from horse milk. Group I is almost insoluble at acid and neutral pH, and is rather heterogeneous on alkaline gels with or without sodium dodecyl sulphate. Group II shows strong similarity to beta-casein from other species, as concluded from its amino acid composition and its N- and C-terminal sequences. This group consists of five electrophoretically distinguishable forms, all containing ester phosphate groups but no carbohydrate. Group III is composed of C-terminal fragments of the beta-like (group II) fraction and probably arises from the action of a plasmin-like enzyme present in horse milk. It does not contain phosphate or carbohydrate. Homology of this group with bovine gamma-caseins is demonstrated. Both beta- and gamma-like caseins are more soluble at 4 degrees C than at room temperature.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 2248-2248
Author(s):  
Kalpna Gupta ◽  
Chunsheng Chen ◽  
Marna E. Ericson ◽  
Robert P. Hebbel ◽  
Yunfang Li

Abstract Pain in sickle cell disease (SCD) is characterized by chronic vasculopathy. Characterization of pain and vasculature may be critical to improve the analgesic ability of opioids in treating pain in SCD. Therefore, we examined the association between vasculature, innervation and pain in a transgenic mouse model of SCD (BERK) and control mice (HbABERK). Pain behavior was analyzed using paw withdrawal latencies (PWL) using Hargreave’s device for thermal hyperalgesia. A radiant heat stimulus was applied to the plantar surface of each hind paw from underneath the glass floor with a projector lamp bulb (CXL/CXR, 8 V, 50 W). PWL to the nearest 0.1 s was automatically recorded upon paw withdrawal. Paws were alternated randomly to preclude “order” effects. We observed that 5 mo old sickle mice showed significantly lower thresholds to noxious heat than controls (p=0.002 for females; and p=0.04 for males; n=5–7 and 15 observations/mouse). Females showed a significantly shorter latency than their respective males (control, p=0.03 and sickle, p=0.01), i.e., they were more sensitive to thermal stimuli. No significant difference was observed between sickle and control nor male and female mice (p &gt; 0.05, n = 5–7) for mechanical allodynia using von Frey filaments, suggesting that sickle mice show increased sensitivity to thermal hyperalgesia. BERK mice were subcutaneously injected with 0.7 mg morphine/Kg mice/day (equivalent to 50 mg/70 kg /day/ human adult) with an added increment of 0.14 mg/day/Kg for each week for three different time periods; Group I, treated for 6 weeks, Group II treated for 6 weeks followed by withdrawal for 6 weeks and Group III treated for 12 weeks. Morphine treatment for 6 weeks as well as 12 weeks resulted in a ∼50–75% increase in PWL vs PBS, suggesting that chronic morphine treatment decreased hyperalgesia in sickle mice. The anti-hyperalgesic effect of morphine was antagonized by simultaneous co-administration of naloxone (2 mcg/Kg/day), suggesting an opioid receptor mediated effect. Naloxone treatment alone did not show any significant effect on PWL. In Group II, withdrawal of morphine for 6 weeks following 6 wks of treatment showed about 35% increase in PWL vs PBS (p&lt;0.005), suggesting that the anti-hyperalgesic effect of morphine continues after its withdrawal. The continued anti-hyperalgesic effect of morphine following withdrawal could be secondary to its vasoregulatory effect. Indeed, confocal microscopy of skin sections revealed disorganized and stringy blood vessels, nerves and lymphatics in sickle mice vs. control. Deep blood vessels and nerve plexus, as well as the skin, were appreciably thicker in controls vs sickle. The diameter of lymphatics and densities of both blood vessels and nerves were significantly lower in sickle vs HbA controls (p= 0.0001 and 0.002, for sub-epidermal and dermal blood vessels, respectively; p=0.04 for lymphatic diameter; p=0.0001 for sub-epidermal, dermal and deep dermal nerve fibers). Functionally, we observed about 30% decrease in subcutaneous O2 measured by Laser Doppler (in real-time) in BERK vs HbA control (p&lt;0.05). Thus, complementary alteration in vasculature and innervation may underlie the chronic pain in SCD. Given that morphine promotes angiogenesis and vasodilation, its prolonged anti-hyperalgesic activity could be due to its vasoregulatory function. Together, these data suggest that intermittent therapy with morphine in SCD may provide analgesia similar to continued therapy and may even be devoid of side-effects.


2018 ◽  
Vol 31 (Supplement_1) ◽  
pp. 56-56
Author(s):  
Michael Weitzendorfer ◽  
Lisa Wahl ◽  
Klaus Emmanuel ◽  
Oliver Koch

Abstract Background The aim of the study was to evaluate, if gastroesophageal reflux disease (GERD), esophageal motility disorders and gastrointestinal symptoms are influenced by the levels of hormones. Methods One-hundred patients with symptoms of GERD were included in the study. All patients routinely underwent 24-hours esophageal impedance pH-monitoring (MII-pH) and high-resolution esophageal manometry (HRM). Symptoms were evaluated using the Reflux-symptom index (RSI) and symptom check list (SCL) questionnaire. Blood samples were taken to analyze the levels of thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free tetraiodothyronine (FT4), gastrin, vasoactive intestinal peptide (VIP) and calcitonin. According to the results of HRM, patients were subdivided into three motility disorder groups: patients with EGJ (esophageal gastric junction) outflow obstruction or major motility disorders (group I), patients with minor motility disorders (group II) and patients with normal esophageal motility (group III). According to the results of 24h-pH-impedence-monitoring patients were divided in patients with and without objective GERD. Results Complete data was available from 86/100 patients (44 men, 42 women with a median age of 56 years). Motility disorders were found in 38/86 patients (22 in group I, 16 in group II). A pathological DeMeester score was found in 45/86 patients (median score 35). No correlation between different hormone levels and DeMeester score, LES-pressure and patients with motility disorders (group I, II) was found. A significant difference regarding calcitonin level was found between group I and III (P = 0043). Furthermore a strong inverse relation between calcitonin and the Integrated Relaxation Pressure (IRP) was found (r = -0492; P = 0000). Positive correlations were found between VIP and GI-Symptoms (r = 0298; P = 0011), as well as correlations between FT3 and dysphagia (r = 0283, P = 0016). Conclusion Calcitonin could have an effect on the function of the EGJ and esophageal motility. The hormones TSH, FT3, FT4, VIP and gastrin do not affect the motility of the esophagus and the EGJ. The levels of the evaluated hormones do not influence distal acid exposure. Thyroid hormones, as well as VIP seem to influence gastrointestinal symptoms. Disclosure All authors have declared no conflicts of interest.


Sign in / Sign up

Export Citation Format

Share Document